Affiliation:
1. Department of anesthesia and intensive care, Faculty of Medical Technology, The University of Tripoli, Libya. Department of Research, Consultation, and Training, Faculty of Medical Technology, The University of Tripoli, Libya
Abstract
Background and aims. Leukemia significantly contributes to the global cancer burden. Research about leukemia types is limited. In this study, we aimed to evaluate the types of leukemia prevalence related to age, gender, and family history in the western area of Libya. Methodology. A cross-sectional study was conducted involving 100 patients who have leukemia. a questionnaire was filled out for each patient. Descriptive statistics for the prevalence of leukemia types were analyzed to assess associating factors including age, gender, and family history. Statistical calculations were performed using the Microsoft Excel Software Version 2010. Results. Of all ages, the highest rate for all leukemia types was age (46 – 65 y) at 29%, however most prevalent leukemia type was CML with 48% of total cases and ALL was the commonest in children (1-10y). Moreover, AML and CLL were the lowest cases. By both genders, male cases were equal to female cases (50% _ 50%). Only 9% of all types have a family history. Conclusion. It is clear, that the most prevalent leukemia type was CML, especially in adults and ALL type was high in children. Only 9% of cases had a family history and by gender the percentage of males to females was equal. Leukemia is a critical cancer that requires further research on associated risk factors.
Publisher
Faculty of Dentistry Khalij-Libya Dental College
Reference29 articles.
1. 1. Chennamadhavuni A. Leukemia [Internet]. U.S. National Library of Medicine; 2023 [cited 2024 Mar 29]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560490/
2. 2. Emadi A, Law JY. Overview of leukemia - hematology and oncology [Internet]. MSD Manuals; 2024 [cited 2024 Mar 29]. Available from: https://www.msdmanuals.com/professional/hematology-and-oncology/leukemias/overview-of-leukemia
3. 3. Du M;Chen W;Liu K;Wang L;Hu Y;Mao Y;Sun X;Luo Y;Shi J;Shao K;Huang H;Ye D; The global burden of leukemia and its attributable factors in 204 countries and territories: Findings from the global burden of disease 2019 study and projections to 2030 [Internet]. U.S. National Library of Medicine; [cited 2024 Mar 29]. Available from: https://pubmed.ncbi.nlm.nih.gov/35509847/
4. 4. Amini M, Sharma R, Jani C. Gender differences in leukemia outcomes based on health care expenditures using estimates from the Globocan 2020. Archives of Public Health. 2023 Aug 21;81(1). doi:10.1186/s13690-023-01154-8
5. 5. Huang J, Chan SC, Ngai CH, Lok V, Zhang L, Lucero-Prisno DE, et al. Disease burden, risk factors, and trends of leukaemia: A global analysis. Frontiers in Oncology. 2022 Jul 22;12. doi:10.3389/fonc.2022.904292